{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:47:11Z","timestamp":1789958831937,"version":"4.0.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,9,5]],"date-time":"2012-09-05T00:00:00Z","timestamp":1346803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,9,5]],"date-time":"2012-09-05T00:00:00Z","timestamp":1346803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1038\/leu.2012.258","type":"journal-article","created":{"date-parts":[[2012,9,5]],"date-time":"2012-09-05T06:42:55Z","timestamp":1346827375000},"page":"619-628","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["C\/EBP\u03b2 promotes BCR\u2013ABL-mediated myeloid expansion and leukemic stem cell exhaustion"],"prefix":"10.1038","volume":"27","author":[{"given":"Y","family":"Hayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Kamio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Ashihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Fujiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D G","family":"Tenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,5]]},"reference":[{"key":"BFleu2012258_CR1","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.anndiagpath.2006.12.002","volume":"11","author":"CV Cotta","year":"2007","unstructured":"Cotta CV, Bueso-Ramos CE . New insights into the pathobiology and treatment of chronic myelogenous leukemia. Ann Diagn Pathol 2007; 11: 68\u201378.","journal-title":"Ann Diagn Pathol"},{"key":"BFleu2012258_CR2","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nrc1567","volume":"5","author":"R Ren","year":"2005","unstructured":"Ren R . Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat Rev Cancer 2005; 5: 172\u2013183.","journal-title":"Nat Rev Cancer"},{"key":"BFleu2012258_CR3","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","volume":"340","author":"CL Sawyers","year":"1999","unstructured":"Sawyers CL . Chronic myeloid leukemia. N Engl J Med 1999; 340: 1330\u20131340.","journal-title":"N Engl J Med"},{"key":"BFleu2012258_CR4","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nrc2147","volume":"7","author":"JV Melo","year":"2007","unstructured":"Melo JV, Barnes DJ . Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nat Rev Cancer 2007; 7: 441\u2013453.","journal-title":"Nat Rev Cancer"},{"key":"BFleu2012258_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/71691","volume":"24","author":"CS Huettner","year":"2000","unstructured":"Huettner CS, Zhang P, Van Etten RA, Tenen DG . Reversibility of acute B-cell leukaemia induced by BCR-ABL1. Nat Genet 2000; 24: 57\u201360.","journal-title":"Nat Genet"},{"key":"BFleu2012258_CR6","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1182\/blood-2003-03-0768","volume":"102","author":"CS Huettner","year":"2003","unstructured":"Huettner CS, Koschmieder S, Iwasaki H, Iwasaki-Arai J, Radomska HS, Akashi K et al. Inducible expression of BCR\/ABL using human CD34 regulatory elements results in a megakaryocytic myeloproliferative syndrome. Blood 2003; 102: 3363\u20133370.","journal-title":"Blood"},{"key":"BFleu2012258_CR7","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1182\/blood-2003-12-4369","volume":"105","author":"S Koschmieder","year":"2005","unstructured":"Koschmieder S, Gottgens B, Zhang P, Iwasaki-Arai J, Akashi K, Kutok JL et al. Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis. Blood 2005; 105: 324\u2013334.","journal-title":"Blood"},{"key":"BFleu2012258_CR8","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMra020777","volume":"349","author":"JM Goldman","year":"2003","unstructured":"Goldman JM, Melo JV . Chronic myeloid leukemia--advances in biology and new approaches to treatment. N Engl J Med 2003; 349: 1451\u20131464.","journal-title":"N Engl J Med"},{"key":"BFleu2012258_CR9","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1182\/blood-2005-06-2209","volume":"106","author":"S Kimura","year":"2005","unstructured":"Kimura S, Naito H, Segawa H, Kuroda J, Yuasa T, Sato K et al. NS-187, a potent and selective dual Bcr-Abl\/Lyn tyrosine kinase inhibitor, is a novel agent for imatinib-resistant leukemia. Blood 2005; 106: 3948\u20133954.","journal-title":"Blood"},{"key":"BFleu2012258_CR10","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1056\/NEJMoa062867","volume":"355","author":"BJ Druker","year":"2006","unstructured":"Druker BJ, Guilhot F, O\u2019Brien SG, Gathmann I, Kantarjian H, Gattermann N et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 2006; 355: 2408\u20132417.","journal-title":"N Engl J Med"},{"key":"BFleu2012258_CR11","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1182\/blood-2007-03-080689","volume":"110","author":"HM Kantarjian","year":"2007","unstructured":"Kantarjian HM, Giles F, Gattermann N, Bhalla K, Alimena G, Palandri F et al. Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance. Blood 2007; 110: 3540\u20133546.","journal-title":"Blood"},{"key":"BFleu2012258_CR12","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/leu.2008.84","volume":"22","author":"A Hochhaus","year":"2008","unstructured":"Hochhaus A, Baccarani M, Deininger M, Apperley JF, Lipton JH, Goldberg SL et al. Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib. Leukemia 2008; 22: 1200\u20131206.","journal-title":"Leukemia"},{"key":"BFleu2012258_CR13","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1056\/NEJMoa040258","volume":"351","author":"CH Jamieson","year":"2004","unstructured":"Jamieson CH, Ailles LE, Dylla SJ, Muijtjens M, Jones C, Zehnder JL et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med 2004; 351: 657\u2013667.","journal-title":"N Engl J Med"},{"key":"BFleu2012258_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1385\/SCR:1:3:181","volume":"1","author":"E Passegue","year":"2005","unstructured":"Passegue E, Weisman IL . Leukemic stem cells: where do they come from? Stem Cell Rev 2005; 1: 181\u2013188.","journal-title":"Stem Cell Rev"},{"key":"BFleu2012258_CR15","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/leu.2008.392","volume":"23","author":"I Bruns","year":"2009","unstructured":"Bruns I, Czibere A, Fischer JC, Roels F, Cadeddu RP, Buest S et al. The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescence. Leukemia 2009; 23: 892\u2013899.","journal-title":"Leukemia"},{"key":"BFleu2012258_CR16","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1038\/nature03669","volume":"435","author":"F Michor","year":"2005","unstructured":"Michor F, Hughes TP, Iwasa Y, Branford S, Shah NP, Sawyers CL et al. Dynamics of chronic myeloid leukaemia. Nature 2005; 435: 1267\u20131270.","journal-title":"Nature"},{"key":"BFleu2012258_CR17","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood-2005-07-2947","volume":"107","author":"M Copland","year":"2006","unstructured":"Copland M, Hamilton A, Elrick LJ, Baird JW, Allan EK, Jordanides N et al. Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction. Blood 2006; 107: 4532\u20134539.","journal-title":"Blood"},{"key":"BFleu2012258_CR18","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/S1470-2045(10)70233-3","volume":"11","author":"FX Mahon","year":"2010","unstructured":"Mahon FX, Rea D, Guilhot J, Guilhot F, Huguet F, Nicolini F et al. Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial. Lancet Oncol 2010; 11: 1029\u20131035.","journal-title":"Lancet Oncol"},{"key":"BFleu2012258_CR19","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1172\/JCI35721","volume":"121","author":"AS Corbin","year":"2011","unstructured":"Corbin AS, Agarwal A, Loriaux M, Cortes J, Deininger MW, Druker BJ . Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity. J Clin Invest 2011; 121: 396\u2013409.","journal-title":"J Clin Invest"},{"key":"BFleu2012258_CR20","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1126\/science.1062538","volume":"293","author":"ME Gorre","year":"2001","unstructured":"Gorre ME, Mohammed M, Ellwood K, Hsu N, Paquette R, Rao PN et al. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 2001; 293: 876\u2013880.","journal-title":"Science"},{"key":"BFleu2012258_CR21","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1182\/blood.V99.9.3472","volume":"99","author":"S Branford","year":"2002","unstructured":"Branford S, Rudzki Z, Walsh S, Grigg A, Arthur C, Taylor K et al. High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR\/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance. Blood 2002; 99: 3472\u20133475.","journal-title":"Blood"},{"key":"BFleu2012258_CR22","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/ni1354","volume":"7","author":"H Hirai","year":"2006","unstructured":"Hirai H, Zhang P, Dayaram T, Hetherington CJ, Mizuno S, Imanishi J et al. C\/EBPbeta is required for \u2018emergency\u2019 granulopoiesis. Nat Immunol 2006; 7: 732\u2013739.","journal-title":"Nat Immunol"},{"key":"BFleu2012258_CR23","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1101\/gad.8.23.2831","volume":"8","author":"S Tsai","year":"1994","unstructured":"Tsai S, Bartelmez S, Sitnicka E, Collins S . Lymphohematopoietic progenitors immortalized by a retroviral vector harboring a dominant-negative retinoic acid receptor can recapitulate lymphoid, myeloid, and erythroid development. Genes Dev 1994; 8: 2831\u20132841.","journal-title":"Genes Dev"},{"key":"BFleu2012258_CR24","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1002\/j.1460-2075.1995.tb07185.x","volume":"14","author":"I Screpanti","year":"1995","unstructured":"Screpanti I, Romani L, Musiani P, Modesti A, Fattori E . Lazzaro D et al. Lymphoproliferative disorder and imbalanced T-helper response in C\/EBP beta-deficient mice. EMBO J 1995; 14: 1932\u20131941.","journal-title":"EMBO J"},{"key":"BFleu2012258_CR25","first-page":"136","volume":"1","author":"RG Hawley","year":"1994","unstructured":"Hawley RG, Lieu FH, Fong AZ, Hawley TS . Versatile retroviral vectors for potential use in gene therapy. Gene Ther 1994; 1: 136\u2013138.","journal-title":"Gene Ther"},{"key":"BFleu2012258_CR26","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1128\/MCB.18.7.3871","volume":"18","author":"M Onishi","year":"1998","unstructured":"Onishi M, Nosaka T, Misawa K, Mui AL, Gorman D, McMahon M et al. Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation. Mol Cell Biol 1998; 18: 3871\u20133879.","journal-title":"Mol Cell Biol"},{"key":"BFleu2012258_CR27","doi-asserted-by":"publisher","first-page":"5691","DOI":"10.1128\/MCB.16.10.5691","volume":"16","author":"R Moriggl","year":"1996","unstructured":"Moriggl R, Gouilleux-Gruart V, Jahne R, Berchtold S, Gartmann C, Liu X et al. Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype. Mol Cell Biol 1996; 16: 5691\u20135700.","journal-title":"Mol Cell Biol"},{"key":"BFleu2012258_CR28","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/sj.gt.3301206","volume":"7","author":"S Morita","year":"2000","unstructured":"Morita S, Kojima T, Kitamura T . Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther 2000; 7: 1063\u20131066.","journal-title":"Gene Ther"},{"key":"BFleu2012258_CR29","doi-asserted-by":"publisher","first-page":"11872","DOI":"10.1073\/pnas.172384399","volume":"99","author":"MG Manz","year":"2002","unstructured":"Manz MG, Miyamoto T, Akashi K, Weissman IL . Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci USA 2002; 99: 11872\u201311877.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2012258_CR30","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/sj.leu.2404549","volume":"21","author":"E Diaz-Blanco","year":"2007","unstructured":"Diaz-Blanco E, Bruns I, Neumann F, Fischer JC, Graef T, Rosskopf M et al. Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase. Leukemia 2007; 21: 494\u2013504.","journal-title":"Leukemia"},{"key":"BFleu2012258_CR31","first-page":"247","volume":"13","author":"K Shuai","year":"1996","unstructured":"Shuai K, Halpern J, ten Hoeve J, Rao X, Sawyers CL . Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia. Oncogene 1996; 13: 247\u2013254.","journal-title":"Oncogene"},{"key":"BFleu2012258_CR32","doi-asserted-by":"publisher","first-page":"31704","DOI":"10.1074\/jbc.271.49.31704","volume":"271","author":"RL Ilaria","year":"1996","unstructured":"Ilaria RL, Van Etten RA . P210 and P190(BCR\/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members. J Biol Chem 1996; 271: 31704\u201331710.","journal-title":"J Biol Chem"},{"key":"BFleu2012258_CR33","doi-asserted-by":"publisher","first-page":"4917","DOI":"10.1182\/blood-2005-10-4110","volume":"107","author":"D Ye","year":"2006","unstructured":"Ye D, Wolff N, Li L, Zhang S, Ilaria RL . STAT5 signaling is required for the efficient induction and maintenance of CML in mice. Blood 2006; 107: 4917\u20134925.","journal-title":"Blood"},{"key":"BFleu2012258_CR34","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/sj.leu.2403241","volume":"18","author":"LS Steelman","year":"2004","unstructured":"Steelman LS, Pohnert SC, Shelton JG, Franklin RA, Bertrand FE, McCubrey JA . JAK\/STAT, Raf\/MEK\/ERK, PI3K\/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia 2004; 18: 189\u2013218.","journal-title":"Leukemia"},{"key":"BFleu2012258_CR35","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1158\/0008-5472.CAN-04-3888","volume":"65","author":"MG Kharas","year":"2005","unstructured":"Kharas MG, Fruman DA . ABL oncogenes and phosphoinositide 3-kinase: mechanism of activation and downstream effectors. Cancer Res 2005; 65: 2047\u20132053.","journal-title":"Cancer Res"},{"key":"BFleu2012258_CR36","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1182\/blood-2008-03-144790","volume":"113","author":"A Quintas-Cardama","year":"2009","unstructured":"Quintas-Cardama A, Cortes J . Molecular biology of bcr-abl1-positive chronic myeloid leukemia. Blood 2009; 113: 1619\u20131630.","journal-title":"Blood"},{"key":"BFleu2012258_CR37","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1182\/blood-2005-08-3181","volume":"107","author":"C Guerzoni","year":"2006","unstructured":"Guerzoni C, Bardini M, Mariani SA, Ferrari-Amorotti G, Neviani P, Panno ML et al. Inducible activation of CEBPB, a gene negatively regulated by BCR\/ABL, inhibits proliferation and promotes differentiation of BCR\/ABL-expressing cells. Blood 2006; 107: 4080\u20134089.","journal-title":"Blood"},{"key":"BFleu2012258_CR38","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1182\/blood-2002-01-0043","volume":"101","author":"C Schuster","year":"2003","unstructured":"Schuster C, Forster K, Dierks H, Elsasser A, Behre G, Simon N et al. The effects of Bcr-Abl on C\/EBP transcription-factor regulation and neutrophilic differentiation are reversed by the Abl kinase inhibitor imatinib mesylate. Blood 2003; 101: 655\u2013663.","journal-title":"Blood"},{"key":"BFleu2012258_CR39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1182\/blood.V83.1.119.bloodjournal831119","volume":"83","author":"RA Steinman","year":"1994","unstructured":"Steinman RA, Tweardy DJ . Granulocyte colony-stimulating factor receptor mRNA upregulation is an immediate early marker of myeloid differentiation and exhibits dysfunctional regulation in leukemic cells. Blood 1994; 83: 119\u2013127.","journal-title":"Blood"},{"key":"BFleu2012258_CR40","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S0301-472X(02)00817-2","volume":"30","author":"Y Du","year":"2002","unstructured":"Du Y, Campbell JL, Nalbant D, Youn H, Bass AC, Cobos E et al. Mapping gene expression patterns during myeloid differentiation using the EML hematopoietic progenitor cell line. Exp Hematol 2002; 30: 649\u2013658.","journal-title":"Exp Hematol"},{"key":"BFleu2012258_CR41","doi-asserted-by":"publisher","first-page":"4322","DOI":"10.1182\/blood-2002-03-0835","volume":"101","author":"MD Bjerregaard","year":"2003","unstructured":"Bjerregaard MD, Jurlander J, Klausen P, Borregaard N, Cowland JB . The in vivo profile of transcription factors during neutrophil differentiation in human bone marrow. Blood 2003; 101: 4322\u20134332.","journal-title":"Blood"},{"key":"BFleu2012258_CR42","doi-asserted-by":"publisher","first-page":"17967","DOI":"10.1073\/pnas.0808303105","volume":"105","author":"Y Minami","year":"2008","unstructured":"Minami Y, Stuart SA, Ikawa T, Jiang Y, Banno A, Hunton IC et al. BCR-ABL-transformed GMP as myeloid leukemic stem cells. Proc Natl Acad Sci USA 2008; 105: 17967\u201317972.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2012258_CR43","doi-asserted-by":"publisher","first-page":"6188","DOI":"10.1038\/sj.onc.1204834","volume":"20","author":"S Xie","year":"2001","unstructured":"Xie S, Wang Y, Liu J, Sun T, Wilson MB, Smithgall TE et al. Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation. Oncogene 2001; 20: 6188\u20136195.","journal-title":"Oncogene"},{"key":"BFleu2012258_CR44","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/emmm.201000062","volume":"2","author":"A Hoelbl","year":"2010","unstructured":"Hoelbl A, Schuster C, Kovacic B, Zhu B, Wickre M, Hoelzl MA et al. Stat5 is indispensable for the maintenance of bcr\/abl-positive leukaemia. EMBO Mol Med 2010; 2: 98\u2013110.","journal-title":"EMBO Mol Med"},{"key":"BFleu2012258_CR45","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1182\/blood.V90.5.1768","volume":"90","author":"GM Feldman","year":"1997","unstructured":"Feldman GM, Rosenthal LA, Liu X, Hayes MP, Wynshaw-Boris A, Leonard WJ et al. STAT5A-deficient mice demonstrate a defect in granulocyte-macrophage colony-stimulating factor-induced proliferation and gene expression. Blood 1997; 90: 1768\u20131776.","journal-title":"Blood"},{"key":"BFleu2012258_CR46","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.1182\/blood-2009-04-216390","volume":"114","author":"A Kimura","year":"2009","unstructured":"Kimura A, Rieger MA, Simone JM, Chen W, Wickre MC, Zhu BM et al. The transcription factors STAT5A\/B regulate GM-CSF-mediated granulopoiesis. Blood 2009; 114: 4721\u20134728.","journal-title":"Blood"},{"key":"BFleu2012258_CR47","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1182\/blood-2007-04-087213","volume":"111","author":"T Akagi","year":"2008","unstructured":"Akagi T, Saitoh T, O\u2019Kelly J, Akira S, Gombart AF, Koeffler HP . Impaired response to GM-CSF and G-CSF, and enhanced apoptosis in C\/EBPbeta-deficient hematopoietic cells. Blood 2008; 111: 2999\u20133004.","journal-title":"Blood"},{"key":"BFleu2012258_CR48","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1182\/blood-2009-12-259630","volume":"116","author":"H Zhang","year":"2010","unstructured":"Zhang H, Nguyen-Jackson H, Panopoulos AD, Li HS, Murray PJ, Watowich SS . STAT3 controls myeloid progenitor growth during emergency granulopoiesis. Blood 2010; 116: 2462\u20132471.","journal-title":"Blood"},{"key":"BFleu2012258_CR49","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/ni.1656","volume":"9","author":"W Liao","year":"2008","unstructured":"Liao W, Schones DE, Oh J, Cui Y, Cui K, Roh TY et al. Priming for T helper type 2 differentiation by interleukin 2-mediated induction of interleukin 4 receptor alpha-chain expression. Nat Immunol 2008; 9: 1288\u20131296.","journal-title":"Nat Immunol"},{"key":"BFleu2012258_CR50","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/ni.1995","volume":"12","author":"XP Yang","year":"2011","unstructured":"Yang XP, Ghoreschi K, Steward-Tharp SM, Rodriguez-Canales J, Zhu J, Grainger JR et al. Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5. Nat Immunol 2011; 12: 247\u2013254.","journal-title":"Nat Immunol"},{"key":"BFleu2012258_CR51","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1182\/blood-2009-04-215376","volume":"115","author":"M Schemionek","year":"2010","unstructured":"Schemionek M, Elling C, Steidl U, Baumer N, Hamilton A, Spieker T et al. BCR-ABL enhances differentiation of long-term repopulating hematopoietic stem cells. Blood 2010; 115: 3185\u20133195.","journal-title":"Blood"},{"key":"BFleu2012258_CR52","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.4161\/cc.5.12.2808","volume":"5","author":"C Guerzoni","year":"2006","unstructured":"Guerzoni C, Ferrari-Amorotti G, Bardini M, Mariani SA, Calabretta B . Effects of C\/EBPalpha and C\/EBPbeta in BCR\/ABL-expressing cells: differences and similarities. Cell Cycle 2006; 5: 1254\u20131257.","journal-title":"Cell Cycle"},{"key":"BFleu2012258_CR53","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ejim.2006.04.004","volume":"17","author":"V Sakka","year":"2006","unstructured":"Sakka V, Tsiodras S, Giamarellos-Bourboulis EJ, Giamarellou H . An update on the etiology and diagnostic evaluation of a leukemoid reaction. Eur J Intern Med 2006; 17: 394\u2013398.","journal-title":"Eur J Intern Med"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2012258.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2012258","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2012258.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T15:46:00Z","timestamp":1648741560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2012258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,5]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["BFleu2012258"],"URL":"https:\/\/doi.org\/10.1038\/leu.2012.258","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,5]]},"assertion":[{"value":"17 July 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}